Abstract
The current chapter focuses on the use of filamentous phages to display, modify, and characterize cytokines, which are proteins belonging to a versatile group of essential mediators involved in cell-cell communication. Cytokines exhibit a considerable diversity, both in functions and in structural features underlying their biological effects. A broad variety of cytokines have been successfully displayed on phages, allowing the high-throughput study of their binding properties and biological activities and the discovery of novel therapeutics through directed evolution. The technical singularities and some potential applications of cytokine phage display are illustrated here with the case of Interleukin-2, a prototypic member of the four-alpha-helix bundle cytokine family playing a pivotal role in the immune response and having a long history of therapeutic use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith GP (1985) Filamentous fusion page: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991) By-passing immunization-human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581–597
Felici F, Castagnoli L, Musacchio A, Japelli R, Cesareni G (1991) Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 222:301–310
Smith GP, Petrenko VA (1997) Phage display. Chem Rev 97:391–410
Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008) High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer 113:293–301
Koreth J, Phil D, Matsuoka K, Kim HT, Mc Donough SM, Bindra B, Alyea EP, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, Tzachanis D, Joyce RM, Avigan DE, Antin JH, Ritz J, Soiffer RJ (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365:2055–2066
Rao BM, Driver L, Lauffenburger DA, Wittrup KD (2005) High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth. Biochemistry 44:10696–10701
Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC (2012) Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’. Nature 484:529–533
Carmenate T, Pacios A, Enamorado M, Moreno E, Garcia-Martinez K, Fuente D, Leon K (2013) Human Interleukin-2 mutein with higher antitumor efficacy than wild type IL-2. J Immunol 190:6230–6238
Mitra S, Ring AM, Amarnath S, Spangler JB, Li P, Ju W, Fischer S, Oh J, Spolski R, Weiskopf K, Kohrt H, Foley JE, Rajagopalan S, Long EO, Fowler DH, Waldmann TA, Garcia KC, Leonard WJ (2015) Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps. Immunity 42:826–838
Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H, Offord RE, Pancino G, Debre P, Gorochov G (2003) Human Immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 77:6637–6644
Gram H, Strittmatter U, Lorenz M, Gluck D, Zenke G (1993) Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies. J Immunol Methods 161:169–176
Kalie E, Jaitin DA, Abramovich R, Schreiber G (2007) An interferon alpha-2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. J Biol Chem 282:11602–11611
Shibata H, Yoshioka Y, Ikemizu S, Kobayashi K, Yamamoto Y, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Hayakawa T, Nagata S, Yamagata Y, Mayumi T, Kamada H, Tsutsumi Y (2004) Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res 10:8293–8300
Buchli PJ, Wu Z, Ciardelli TL (1997) The functional display of interleukin-2 on filamentous phage. Arch Biochem Biophys 339:79–84
Vispo NS, Callejo M, Ojalvo AG, Santos A, Chinea G, Gavilondo JV, Araña MJ (1997) Displaying human interleukin-2 on the surface of bacteriophage. Immunotechnology 3:185–193
Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A 82:488–492
Rojas G, Pupo A, Leon K, Avellanet J, Carmenate T, Sidhu S (2013) Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: a versatile platform for fine epitope mapping. Immunobiology 218:105–113
Rojas G, Infante YC, Pupo A, Carmenate T (2014) Fine specificity of antibodies against Interleukin-2 explains their paradoxical immunomodulatory effects. mAbs 6:273–285
Rojas G, Carmenate T, Leon K (2015) Molecular dissection of the interactions of an antitumor Interleukin-2-derived mutein on a phage display-based platform. J Mol Recognit 28:261–268
Acknowledgment
G. Rojas is partially supported by a Georg Forster research fellowship awarded by the Alexander von Humboldt Foundation, Germany.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Rojas, G., Carmenate, T. (2018). Phagekines: Screening Binding Properties and Biological Activity of Functional Cytokines Displayed on Phages. In: Hust, M., Lim, T. (eds) Phage Display. Methods in Molecular Biology, vol 1701. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7447-4_30
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7447-4_30
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7446-7
Online ISBN: 978-1-4939-7447-4
eBook Packages: Springer Protocols